A State Of Truth

The Purpose Of This Page Is To Take Away Your Illusions

Posts for Tag: cancer industry

DMSO Is a Miraculous Therapy for Neurological Diseases

Dimethyl sulfoxide (DMSO) is a simple, inexpensive compound found throughout nature whose remarkable properties allow it both to treat a wide range of illnesses and to facilitate the use of many different (FDA approved) medical therapies. Yet, it exists in a strange limbo: it is one of the most extensively studied and used medicinal compounds, but most mainstream sources insist there’s no evidence it works for anything beyond its single FDA-approved use, interstitial cystitis, despite the fact that physicians and scientists, seeing its promise, independently conducted tens of thousands of studies demonstrating its therapeutic utility and that DMSO, on the basis of that data, is widely used in foreign medical systems. [Read More]

USDA’s No GMO Label Doesn’t Mean No Genetic Engineering

A food package carries no bioengineered disclosure. Does that mean no genetic engineering went into the food?

No. USDA’s bioengineered food disclosure standard leaves entire categories of genetically engineered foods and ingredients outside mandatory disclosure.

Easing restrictions on natural substances with credible histories of safe use makes sense. Yet natural products face persistent calls for tighter regulation, alongside efforts to suppress truthful information about their benefits.

Meanwhile, novel technologies that fundamentally alter our food are riding a wave of deregulation - even as their implications demand rigorous scrutiny and full transparency.

These priorities are backwards. [Read More]

The Rise in Cancer They Can't Explain Away


A mouse study, a wave of new global cancer data, and disturbing testimony out of Canada are all pointing in the same direction. Jefferey digs into what the lipid nanoparticle from the COVID-19 vaccine might be doing to your immune system, and why some researchers think this issue is only getting started.

How DMSO Heals the Blood Vessels and Could Save Millions From Strokes

Decades ago, I learned that DMSO was an excellent therapy for strokes and then subsequently had numerous experiences where someone I told to take DMSO had their full stroke resolve on the way to the hospital (sparing them from a life of expected disability), after which I started also using DMSO for successful post-stroke recoveries. When you consider both how debilitating strokes typically are and that, for decades, there has been only piecemeal progress on reducing the suffering they cause, it’s hard to put into words how upsetting this has been for me. [Read More]


DMSO: Overview of Some Benefits and Dosages

DMSO is an organosulfur compound used as a topical pain reliever and anti-inflammatory agent. It activates cellular stress responses at low to moderate levels, boosting resilience against future threats.

Research shows DMSO inhibits cancer cell growth and triggers apoptosis in various cancer cell lines, suggesting promise as a targeted therapy for slowing or stopping cancer progression.

In a mouse model of Alzheimer’s, low-dose DMSO improved visual function, likely due to its antioxidant properties. It may be useful as an early intervention in neurodegenerative diseases.

DMSO is related to MSM, which has shown benefits for joint health. It also exhibits antibacterial properties, inhibiting growth of various bacterial strains at relatively low concentrations.

While promising, DMSO has side effects including a garlic-like odour and skin irritation. It increases absorption of other substances and may interact with certain medications, necessitating caution in its use. [Read More]

Trump/Kennedy FDA Approves Moderna mRNA-1010 Influenza Shot 'mFLUSIVA' with Less Than 1% Absolute Benefit and 6 Times More Severe Reactions

Moderna, Inc. announced that the U.S. Food and Drug Administration (FDA) has “approved mFLUSIVA® (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older.”

Even though the alleged benefit for adults 65 and older was never proven.

The move comes after the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously in June that the “benefits” of Moderna’s experimental mRNA influenza vaccine “outweigh its risks.” [Read More]